Neuromedin B modulates phosphate-induced vascular calcification

Area of Science:

• Cardiovascular Biology
• Vascular Biology
• Biomedical Research

Background:

• Vascular calcification, the deposition of calcium phosphate in blood vessels, significantly increases cardiovascular disease risk.
• Understanding the molecular mechanisms driving vascular calcification is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the role of neuromedin B (NMB) and its receptor in the development of vascular calcification.
• To evaluate the therapeutic potential of targeting the NMB-NMB receptor axis in vascular calcification.

Main Methods:

• Examined NMB and NMB receptor expression in phosphate-induced vascular smooth muscle cell (VSMC) calcification.
• Utilized NMB silencing and a specific NMB receptor antagonist (PD168368) in cellular and animal models.
• Assessed effects on VSMC osteogenic differentiation, Wnt/β-catenin signaling, and apoptosis.
• Evaluated PD168368 efficacy in cultured aortic rings and a rat model of chronic kidney disease.

Main Results:

• NMB and its receptor expression were upregulated in phosphate-induced VSMC calcification.
• Inhibition of NMB or blockade of its receptor with PD168368 suppressed VSMC osteogenic differentiation and apoptosis.
• PD168368 treatment attenuated arterial calcification in vitro and in vivo.
• The NMB-NMB receptor axis was found to modulate Wnt/β-catenin signaling.

Conclusions:

• The neuromedin B (NMB)-NMB receptor pathway plays a significant role in promoting vascular calcification.
• Targeting the NMB-NMB receptor axis, for example with PD168368, presents a promising therapeutic avenue for treating vascular calcification.
• Further research into this axis could lead to novel diagnostic and therapeutic strategies for cardiovascular complications associated with vascular calcification.